211.5: Targeted delivery of galunisertib using machine perfusion reduces fibrogenesis in an integrated ex vivo renal transplant and fibrogenesis model
TRANSPLANTATION（2023）
摘要
Our findings demonstrate the value of using machine perfusion for administering anti- fibrotic drugs, such as galunisertib, proving it to be an effective example of repurposing.
更多查看译文
关键词
vivo renal transplant,galunisertib,fibrogenesis model,machine perfusion
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要